2025/l 2026l Update)l Diagnosisl &l
Managementl inl Psychiatricl Mentall
Healthl IIl Guide|l Questionsl &l Answers|l
Gradel A|l 100%l Correctl (Verifiedl
Solutions)-l Chamberlain
QUESTION
Criterial forl seperationl anxietyl inl children
Answer:
Thel conditionl mayl bel triggeredl byl stressl thatl leadsl tol separationl froml al lovedl onel andl
isl diagnosedl whenl symptomsl arel excessivel forl thel developmentall agel andl interferel withl
dailyl functioning
QUESTION
Criterial forl sociall anxietyl inl children
Answer:
consistentlyl presentl symptomsl forl 6+l mol inl similarl situations.
-wl peersl andl adults
QUESTION
Screenl forl Childl Anxietyl Relatedl Disordersl tooll andl scoringl uses
Answer:
-SCAREDl tooll screensl forl alll typesl ofl childhoodl anxietyl disorders
-includingl generalizedl anxiety,l panicl disorder,l separationl anxiety,l andl sociall anxiety
,-25l +pointsl indicatesl potentiall anxietyl disorder
QUESTION
Emotionall disinhibition
Answer:
-al possiblel late-onsetl sidel effectl inl clientsl whol takel antidepressantl medication.
-treatmentl shouldl ideallyl continuel withl anl antidepressantl atl thel samel dosel forl al minl ofl
6l mol afterl symptomaticl improvementl beforel discontinuation.
-Addingl bupropion-l mayl decreasel disinhibitoryl behaviors
QUESTION
ssril maintenancel phase
Answer:
Aiml isl tol preventl relapsel byl continuingl treatmentl forl thosel withl recurrent,l
severe/chronicl depression.
QUESTION
ssril continuationl phase
Answer:
Aiml isl tol consolidatel treatmentl gainsl andl preventl relapsel forl 6l tol 12l months.
QUESTION
ssril acutel phase
Answer:
Aiml isl tol achievel al significantl reductionl orl disappearancel ofl symptomsl forl 8-12l weeks.
,QUESTION
Adversel effectsl ofl SSRIl inl kids/teens
Answer:
-behaviorall activation!
-irritability,l agitation,l andl impulsivity
-!!Paroxetinel -l SSRIl associatedl withl increasedl suicidall thinking/l actionsl inl
children/adolescentsl andl shouldl NOTl bel usedl tol treatl depressionl inl thisl population!!
-SSRIsl shouldl bel startedl atl lowl dosesl withl dosel increasel orl medicationl changel onlyl
afterl 4l weeks.
-Symptoml severityl shouldl bel assessedl everyl 1-2l weeksl afterl initiatingl medicationl alongl
withl continuousl monitoringl ofl suicidality.
QUESTION
frontlinel ssril forl pedl MDD
Answer:
Fluoxetinel =l frontlinel choicel duel tol itsl efficacy,l lowl cost,l andl sidel effectl profile
QUESTION
txl forl pedl MDD
Answer:
-CBT+l SSRI
-Onlyl al fewl SSRIsl arel approvedl forl usel inl children/l adolescents
-Fluoxetinel =l frontlinel choicel duel tol itsl efficacy,l lowl cost,l andl sidel effectl profile
QUESTION
screenl forl pedl MDD
, Answer:
-Screenl inl agesl 12-18
-PHQ-9Al (forl adolescents)
QUESTION
Symptomsl ofl Pediatricl Unipolarl Depression:
Answer:
Sadnessl orl irritability
Academicl decline
Withdrawall froml friendsl andl family
Lossl ofl interestl inl thingsl ofl pastl enjoyment
Problemsl withl sleep
Appetitel and/orl weightl changes
Feelingsl ofl guiltl orl beingl misunderstood
Clingingl tol al parent
Unexplainedl crying
Thoughtsl orl actionsl ofl self-harm
QUESTION
girlsl vl boysl MDD
Answer:
-Adolescentl girlsl 3xl morel likelyl tol experiencel depressionl thanl boys
-thoughl boysl havel al higherl ratel ofl depressionl beforel puberty
QUESTION
Commonl comorbidl conditionsl ofl pedl MDD
Answer:
anxietyl disorders/substancel usel disorders